BACKGROUD: Using electronic health data, we sought to identify clinical and physiological parameters that in combination predict neurologic outcomes after aneurysmal subarachnoid hemorrhage (aSAH). METHODS: We conducted a single-center retrospective cohort study of patients admitted with aSAH between 2011 and 2016. A set of 473 predictor variables was evaluated. Our outcome measure was discharge Glasgow Outcome Scale (GOS). For laboratory and physiological data, we computed the minimum, maximum, median, and variance for the first three admission days. We created a penalized logistic regression model to determine predictors of outcome and a multivariate multilevel prediction model to predict poor (GOS 1-2), intermediate (GOS 3), or good (GOS 4-5) outcomes. RESULTS: One hundred and fifty-three patients met inclusion criteria; most were discharged with a GOS of 3. Multivariate analysis predictors of mortality (AUC 0.9198) included APACHE II score, Glasgow Come Scale (GCS), white blood cell (WBC) count, mean arterial pressure, variance of serum glucose, intracranial pressure (ICP), and serum sodium. Predictors of death/dependence versus independence (GOS 4-5)(AUC 0.9456) were levetiracetam, mechanical ventilation, WBC count, heart rate, ICP variance, GCS, APACHE II, and epileptiform discharges. The multiclass prediction model selected GCS, admission APACHE II, periodic discharges, lacosamide, and rebleeding as significant predictors; model performance exceeded 80% accuracy in predicting poor or good outcome and exceeded 70% accuracy for predicting intermediate outcome. CONCLUSIONS: Variance in early physiologic data can impact patient outcomes and may serve as targets for early goal-directed therapy. Electronically retrievable features such as ICP, glucose levels, and electroencephalography patterns should be considered in disease severity and risk stratification scores.
BACKGROUD: Using electronic health data, we sought to identify clinical and physiological parameters that in combination predict neurologic outcomes after aneurysmal subarachnoid hemorrhage (aSAH). METHODS: We conducted a single-center retrospective cohort study of patients admitted with aSAH between 2011 and 2016. A set of 473 predictor variables was evaluated. Our outcome measure was discharge Glasgow Outcome Scale (GOS). For laboratory and physiological data, we computed the minimum, maximum, median, and variance for the first three admission days. We created a penalized logistic regression model to determine predictors of outcome and a multivariate multilevel prediction model to predict poor (GOS 1-2), intermediate (GOS 3), or good (GOS 4-5) outcomes. RESULTS: One hundred and fifty-three patients met inclusion criteria; most were discharged with a GOS of 3. Multivariate analysis predictors of mortality (AUC 0.9198) included APACHE II score, Glasgow Come Scale (GCS), white blood cell (WBC) count, mean arterial pressure, variance of serum glucose, intracranial pressure (ICP), and serum sodium. Predictors of death/dependence versus independence (GOS 4-5)(AUC 0.9456) were levetiracetam, mechanical ventilation, WBC count, heart rate, ICP variance, GCS, APACHE II, and epileptiform discharges. The multiclass prediction model selected GCS, admission APACHE II, periodic discharges, lacosamide, and rebleeding as significant predictors; model performance exceeded 80% accuracy in predicting poor or good outcome and exceeded 70% accuracy for predicting intermediate outcome. CONCLUSIONS: Variance in early physiologic data can impact patient outcomes and may serve as targets for early goal-directed therapy. Electronically retrievable features such as ICP, glucose levels, and electroencephalography patterns should be considered in disease severity and risk stratification scores.
Authors: Vincent Degos; Christian C Apfel; Paola Sanchez; Chantal Colonne; Isabelle Renuit; Frédéric Clarençon; Aurélien Nouet; Anne Laure Boch; Tony Pourmohamad; Helen Kim; Pierre Antoine Gourraud; William L Young; Louis Puybasset Journal: Stroke Date: 2012-02-23 Impact factor: 7.914
Authors: L J Hirsch; S M LaRoche; N Gaspard; E Gerard; A Svoronos; S T Herman; R Mani; H Arif; N Jette; Y Minazad; J F Kerrigan; P Vespa; S Hantus; J Claassen; G B Young; E So; P W Kaplan; M R Nuwer; N B Fountain; F W Drislane Journal: J Clin Neurophysiol Date: 2013-02 Impact factor: 2.177
Authors: Sahar F Zafar; M Brandon Westover; Nicolas Gaspard; Emily J Gilmore; Brandon P Foreman; Kathryn L OʼConnor; Eric S Rosenthal Journal: J Clin Neurophysiol Date: 2016-06 Impact factor: 2.177
Authors: Jeffrey D Klopfenstein; Louis J Kim; Iman Feiz-Erfan; Jonathan S Hott; Pam Goslar; Joseph M Zabramski; Robert F Spetzler Journal: J Neurosurg Date: 2004-02 Impact factor: 5.115
Authors: Jan Claassen; An Vu; Kurt T Kreiter; Robert G Kowalski; Evelyn Y Du; Noeleen Ostapkovich; Brian-Fred M Fitzsimmons; E Sander Connolly; Stephan A Mayer Journal: Crit Care Med Date: 2004-03 Impact factor: 7.598
Authors: Vittorio Stumpo; Victor E Staartjes; Giuseppe Esposito; Carlo Serra; Luca Regli; Alessandro Olivi; Carmelo Lucio Sturiale Journal: Acta Neurochir Suppl Date: 2022
Authors: Tina Nguyen; Kanisha Pope; Paul Capobianco; Mimi Cao-Pham; Soha Hassan; Matthew J Kole; Claire O'Connell; Aaron Wessell; Jonathan Strong; Quincy K Tran Journal: J Emerg Trauma Shock Date: 2020-06-10
Authors: Matthew K McIntyre; Mohamed Halabi; Boyi Li; Andrew Long; Alexander Van Hoof; Adil Afridi; Chirag Gandhi; Meic Schmidt; Chad Cole; Justin Santarelli; Fawaz Al-Mufti; Christian A Bowers Journal: Sci Rep Date: 2021-01-08 Impact factor: 4.379